Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Benefits seen with rhLAMAN in patients with alpha-mannosidosis

Sep. 26, 2012

Sequestosome-1 identified as a biomarker of melanoma

Sep. 25, 2012

Eliglustat efficacy maintained for 4 years in patients with Gaucher's disease

Sep. 25, 2012

First-in-human study of Opal-HIV-Gag(c) terminated

Sep. 25, 2012

Itraconazole shows promise as an antiangiogenic and antitumor agent

Sep. 25, 2012

Bayer College of Medicine presents novel Ndufs4-mutant mouse model

Sep. 21, 2012

Plasma serotonin as indicator of stable heart disease outcomes

Sep. 21, 2012

Identification of a new series of potent and selective NS5B inhibitors

Sep. 21, 2012

Theravance presents new dual MABA bronchodilators for COPD

Sep. 21, 2012

Afatinib demonstrates significant improvements in PFS in the LUX-lung 3 phase III trial

Sep. 21, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026